A citation-based method for searching scientific literature

Ashley V Howell, Mulugeta Gebregziabher, Bruce H Thiers, Chrystal M Paulos, John M Wrangle, Kelly J Hunt, Kristin Wallace. J Geriatr Oncol 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Melanoma in solid organ transplant recipients.
F O Zwald, L J Christenson, E M Billingsley, N C Zeitouni, D Ratner, J Bordeaux, M J Patel, M D Brown, C M Proby, S Euvrard,[...]. Am J Transplant 2010
63
50

Melanoma Risk and Survival among Organ Transplant Recipients.
Hilary A Robbins, Christina A Clarke, Sarah T Arron, Zaria Tatalovich, Amy R Kahn, Brenda Y Hernandez, Lisa Paddock, Elizabeth L Yanik, Charles F Lynch, Bertram L Kasiske,[...]. J Invest Dermatol 2015
67
50

Increasing incidence of melanoma after solid organ transplantation: a retrospective epidemiological study.
Kinda Fattouh, Emilie Ducroux, Evelyne Decullier, Jean Kanitakis, Emmanuel Morelon, Pascale Boissonnat, Laurent Sebbag, Denis Jullien, Sylvie Euvrard. Transpl Int 2017
21
50

Immune Checkpoint Inhibitors in Organ Transplant Patients.
Adam S Kittai, Hayden Oldham, Jeremy Cetnar, Matthew Taylor. J Immunother 2017
76
50

Melanoma Outcomes in Transplant Recipients With Pretransplant Melanoma.
Sarah T Arron, Amanda K Raymond, Elizabeth L Yanik, David Castenson, Charles E McCulloch, Christina A Clarke, Lisa E Paddock, Xiaoling Niu, Eric A Engels. Dermatol Surg 2016
14
50

Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients.
Charles M Balch, John F Thompson, Jeffrey E Gershenwald, Seng-Jaw Soong, Shouluan Ding, Kelly M McMasters, Daniel G Coit, Alexander M M Eggermont, Phyllis A Gimotty, Timothy M Johnson,[...]. Ann Surg Oncol 2014
88
50

The challenge of defining guidelines for sentinel lymph node biopsy in patients with thin primary cutaneous melanomas.
Jeffrey E Gershenwald, Daniel G Coit, Vernon K Sondak, John F Thompson. Ann Surg Oncol 2012
24
50

Survival analysis and sentinel lymph node status in thin cutaneous melanoma: A multicenter observational study.
Antonio Tejera-Vaquerizo, Simone Ribero, Susana Puig, Aram Boada, Sabela Paradela, David Moreno-Ramírez, Javier Cañueto, Blanca de Unamuno, Ana Brinca, Miguel A Descalzo-Gallego,[...]. Cancer Med 2019
16
50


Immune checkpoint inhibitors: recent progress and potential biomarkers.
Pramod Darvin, Salman M Toor, Varun Sasidharan Nair, Eyad Elkord. Exp Mol Med 2018
636
50

Risk of Melanoma Recurrence After Diagnosis of a High-Risk Primary Tumor.
Lena A von Schuckmann, Maria Celia B Hughes, Reza Ghiasvand, Maryrose Malt, Jolieke C van der Pols, Vanessa L Beesley, Kiarash Khosrotehrani, B Mark Smithers, Adele C Green. JAMA Dermatol 2019
27
50

Can we better identify thin cutaneous melanomas that are likely to metastasize and cause death?
Rajmohan Murali, Richard A Scolyer, John F Thompson. Ann Surg Oncol 2012
6
50

Efficacy and tolerance of immune checkpoint inhibitors in transplant patients with cancer: A systematic review.
Thibaut d'Izarny-Gargas, Antoine Durrbach, Mohamad Zaidan. Am J Transplant 2020
25
50

Exposure-response relationships of the efficacy and safety of ipilimumab in patients with advanced melanoma.
Yan Feng, Amit Roy, Eric Masson, Tai-Tsang Chen, Rachel Humphrey, Jeffrey S Weber. Clin Cancer Res 2013
100
50

Targeting the mTOR pathway uncouples the efficacy and toxicity of PD-1 blockade in renal transplantation.
Khashayar Esfahani, Tho-Alfakar Al-Aubodah, Pamela Thebault, Réjean Lapointe, Marie Hudson, Nathalie A Johnson, Dana Baran, Najwa Bhulaiga, Tomoko Takano, Jean-François Cailhier,[...]. Nat Commun 2019
35
50

Melanoma in organ transplant recipients: clinicopathological features and outcome in 100 cases.
R N Matin, D Mesher, C M Proby, J M McGregor, J N Bouwes Bavinck, V del Marmol, S Euvrard, C Ferrandiz, A Geusau, M Hackethal,[...]. Am J Transplant 2008
79
50

Survival after cutaneous melanoma in kidney transplant recipients: a population-based matched cohort study.
C M Vajdic, A H Chong, P J Kelly, N S Meagher, M T Van Leeuwen, A E Grulich, A C Webster. Am J Transplant 2014
32
50

Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
Jeffrey E Gershenwald, Richard A Scolyer, Kenneth R Hess, Vernon K Sondak, Georgina V Long, Merrick I Ross, Alexander J Lazar, Mark B Faries, John M Kirkwood, Grant A McArthur,[...]. CA Cancer J Clin 2017
887
50

Outcomes of melanoma in recipients of solid organ transplant.
Daniel C Dapprich, Roger H Weenig, Audrey L Rohlinger, Amy L Weaver, Katherine K Lim Quan, James H Keeling, John S Walsh, Clark C Otley, Leslie J Christenson. J Am Acad Dermatol 2008
35
50

The incidence and risk factors of de novo skin cancer in the liver transplant recipients.
J Modaresi Esfeh, I A Hanouneh, D Dalal, A Tabba, R Lopez, M Pagadala, B Eghtesad, N N Zein. Int J Organ Transplant Med 2012
9
50

Malignant melanoma in solid transplant recipients: collection of database cases and comparison with surveillance, epidemiology, and end results data for outcome analysis.
Jerry D Brewer, Leslie J Christenson, Amy L Weaver, Daniel C Dapprich, Roger H Weenig, Katherine K Lim, John S Walsh, Clark C Otley, Wida Cherikh, Joseph F Buell,[...]. Arch Dermatol 2011
52
50

Examining the Incidence and Presentation of Melanoma in the Cardiothoracic Transplant Population.
Charles J Puza, Adela R Cardones, Paul J Mosca. JAMA Dermatol 2018
4
50

Use of Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer: A Systematic Review and Meta-analysis.
Jianchun Duan, Longgang Cui, Xiaochen Zhao, Hua Bai, Shangli Cai, Guoqiang Wang, Zhengyi Zhao, Jing Zhao, Shiqing Chen, Jia Song,[...]. JAMA Oncol 2020
93
50

Age favoured overall survival in a large population-based Danish patient cohort treated with anti-PD1 immune checkpoint inhibitor for metastatic melanoma.
Lars Bastholt, Henrik Schmidt, Jon Kroll Bjerregaard, Jørn Herrstedt, Inge Marie Svane. Eur J Cancer 2019
18
50

Improved survival with vemurafenib in melanoma with BRAF V600E mutation.
Paul B Chapman, Axel Hauschild, Caroline Robert, John B Haanen, Paolo Ascierto, James Larkin, Reinhard Dummer, Claus Garbe, Alessandro Testori, Michele Maio,[...]. N Engl J Med 2011
50

Association of Immunotherapy With Overall Survival in Elderly Patients With Melanoma.
Marie Perier-Muzet, Elodie Gatt, Julien Péron, Claire Falandry, Mona Amini-Adlé, Luc Thomas, Stephane Dalle, Amelie Boespflug. JAMA Dermatol 2018
28
50

Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence.
Raju K Vaddepally, Prakash Kharel, Ramesh Pandey, Rohan Garje, Abhinav B Chandra. Cancers (Basel) 2020
271
50

Cancer immunotherapy using checkpoint blockade.
Antoni Ribas, Jedd D Wolchok. Science 2018
50

Correction to: Frequent genetic aberrations in the cell cycle related genes in mucosal melanoma indicate the potential for targeted therapy.
Longwen Xu, Zhiyuan Cheng, Chuanliang Cui, Xiaowen Wu, Huan Yu, Jun Guo, Yan Kong. J Transl Med 2019
1
100

Immunotherapy Outcomes in Advanced Melanoma in Relation to Age.
Krishna Joshi, Dinesh Atwal, Rahul Ravilla, Yadav Pandey, Naveen Yarlagadda, Sunil Kakadia, Issam Makhoul, Laura Hutchins, Fade Mahmoud. Perm J 2020
5
50

Surgery for Unresectable Stage IIIC and IV Melanoma in the Era of New Systemic Therapy.
Stephanie A Blankenstein, Maureen J B Aarts, Franchette W P J van den Berkmortel, Marye J Boers-Sonderen, Alfons J M van den Eertwegh, Margreet G Franken, Jan Willem B de Groot, John B A G Haanen, Geke A P Hospers, Ellen Kapiteijn,[...]. Cancers (Basel) 2020
6
50

Improved survival with ipilimumab in patients with metastatic melanoma.
F Stephen Hodi, Steven J O'Day, David F McDermott, Robert W Weber, Jeffrey A Sosman, John B Haanen, Rene Gonzalez, Caroline Robert, Dirk Schadendorf, Jessica C Hassel,[...]. N Engl J Med 2010
50

Impact of Age on Outcomes with Immunotherapy in Patients with Non-Small Cell Lung Cancer.
Morgan R L Lichtenstein, Ryan D Nipp, Alona Muzikansky, Kelly Goodwin, Danyon Anderson, Richard A Newcomb, Justin F Gainor. J Thorac Oncol 2019
23
50

PD-1/PDL-1 Inhibitors and Cardiotoxicity; Molecular, Etiological and Management Outlines.
Mohammed Safi, Hyat Ahmed, Mahmoud Al-Azab, Yun-Long Xia, Xiu Shan, Mohammed Al-Radhi, Abdullah Al-Danakh, Abdullah Shopit, Jiwei Liu. J Adv Res 2020
3
50

Association of Insurance Status With Presentation, Treatment, and Survival in Melanoma in the Era of Immune Checkpoint Inhibitors.
Varsha Jain, Sriram Venigalla, Vishruth K Reddy, John N Lukens, Tara C Mitchell, Jacob E Shabason. J Immunother 2020
6
50

Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade.
Danielle M Bello, Katherine S Panageas, Travis Hollmann, Alexander N Shoushtari, Parisa Momtaz, Paul B Chapman, Michael A Postow, Margaret K Callahan, Jedd D Wolchok, Mary S Brady,[...]. Ann Surg Oncol 2020
16
50

Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy.
Mehmet Asim Bilen, Julie M Shabto, Dylan J Martini, Yuan Liu, Colleen Lewis, Hannah Collins, Mehmet Akce, Haydn Kissick, Bradley C Carthon, Walid L Shaib,[...]. BMC Cancer 2019
37
50

Correction to: Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy.
Daixi Ren, Yuze Hua, Boyao Yu, Xin Ye, Ziheng He, Chunwei Li, Jie Wang, Yongzhen Mo, Xiaoxu Wei, Yunhua Chen,[...]. Mol Cancer 2020
6
50

Interferon Signaling Is Diminished with Age and Is Associated with Immune Checkpoint Blockade Efficacy in Triple-Negative Breast Cancer.
Jaclyn Sceneay, Gregory J Goreczny, Kristin Wilson, Sara Morrow, Molly J DeCristo, Jessalyn M Ubellacker, Yuanbo Qin, Tyler Laszewski, Daniel G Stover, Victor Barrera,[...]. Cancer Discov 2019
32
50

Trend and socioeconomic disparities in survival outcome of metastatic melanoma after approval of immune checkpoint inhibitors: a population-based study.
Depei Li, Hao Duan, Pingping Jiang, Xiaobing Jiang, Zhenqiang He, Chengcheng Guo, Yonggao Mou. Am J Transl Res 2020
3
50


Older Americans Were Sicker And Faced More Financial Barriers To Health Care Than Counterparts In Other Countries.
Robin Osborn, Michelle M Doty, Donald Moulds, Dana O Sarnak, Arnav Shah. Health Aff (Millwood) 2017
30
50

Impact of Age on Outcomes with Immunotherapy for Patients with Melanoma.
Allison S Betof, Ryan D Nipp, Anita Giobbie-Hurder, Romany A N Johnpulle, Krista Rubin, Samuel M Rubinstein, Keith T Flaherty, Donald P Lawrence, Douglas B Johnson, Ryan J Sullivan. Oncologist 2017
90
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.